Navigation Links
Breast Cancer on Rise Across Middle East

The incidence of breast cancer is increasing rapidly across the Middle East, said doctors from UAE who met in Paris at the 2nd Middle East and Africa Oncology summit .

However, the medical experts agreed that the patients in the region suffering from the disease are living longer, WAM news agency reported.

The good news though, said the doctors from Abu Dhabi's Tawam Hospital, is that breast cancer cases (in UAE) are being caught much earlier, a critical factor in successful treatment of the chronic disease.

Prevention, early diagnosis and proper treatment are the only ways to bring down breast cancer statistics in the UAE. But for post-menopausal women, not all current treatments are safe and effective.

For many years, adjuvant Tamoxifen has been the gold standard for endocrine therapy in early breast cancer. In recent trials, however, third generation aromatase inhibitors, such as Letrozole, have been shown to be more effective than Tamoxifen in advanced disease, neoadjuvant therapy, and adjuvant therapy.

"Endocrine therapy, such as Letrozole, remains a very powerful approach to treating breast cancer in post-menopausal women, and with very low levels of toxicity," said Ian Smith, Professor of Cancer Medicine at the Royal Marsden Hospital and Institute of Cancer Research in London.


'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Breast Cancer Rise Across Middle East

(Date:10/13/2008)...ropean study suggests that the combination of low ...ure from the sun is associated with certain forms ...n (AMD), according to a report in the October issu.../Archives journals. , "The retina is vulnerable...ite as background information in the article. "Whi...
(Date:10/13/2008)...W YORK, Oct. 13 /PRNewswire-USNewswire/ -- As the ...General, Ban Ki-Moon, on fistula is,scheduled to b...o End,Fistula announced a fourfold increase in the...nnual report, the campaign now works to prevent an...ia and the Arab States. When it,was launched in 20...
(Date:10/13/2008)...tional Latino AIDS Awareness Day Encourages Latino.../ --, WHAT, -- Latinos make up almost half of al...ngeles County compared to 19 percent nationally., ...s and encouraging HIV,counseling and testing to co...erved on October 15., -- October 14, Our Communit...
(Date:10/13/2008)...ch alcohol has a greater effect on women, study fo... -- The more alcohol you drink, the more your brai...home message is that, if you drink a lot, you,re g...associate professor of neuroscience and experiment...e Center College of Medicine. "This is something w...
Breaking Medicine News(10 mins):Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 3Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Excess Drinking Shrinks the Brain 2
...that she chants as she decides what to do with her...g is used by many Buddhists celebrities including ...py. Love reportedly wrote on her website: "I chan...night and really thought about where the money sho...
...h Wine Fair (Fenavin) here, India has said it woul...ions in production if a strong element of "price s...tivity does not necessarily mean selling the cheap...of the Delhi Wine Club, told delegates at the thre...
... away for talented actress Kangana Ranaut but that...es she wants in Mr.Right! "I'm going to get marr...find Mr. Right," Kangana told IANS. "He should b...d real... not a mannequin. He has to be a white-co...
...ave found a treatment, which could block the actio...ncer. The enzyme PTP1B appears to fuel tumor grow...in treating the disease. About 40 percent of human...shown to have excessively high levels of this enzy...
Other Medicine News:Health News:India is Uncorking Its Wine Market: Expert 2Health News:Gentle, Real, Well-mannered - Kangana's Mr. Right 2
(Date:10/13/2008)...e Higher Sensitivity and Specificity, than Other ... preferred test in all phases of t...Newswire/ -- AT First Diagnostic LLC an,emerging w... kits, today,announced that a recent evaluation co...rch of the FirstVue(TM) HBSAG Test, was released a...
(Date:10/12/2008)... Combination with Chemotherapy, FREMONT, Calif. O..., a,development-stage pharmaceutical company disco...)-based therapeutics, today announced that the,jou... of siRNA targeting,its proprietary target gene ag...ition dated October 1, 2008. The paper, entitled "...
(Date:10/10/2008)...wswire/ -- Diplomat Specialty,Pharmacy announced t...Specialty Pharmacy to be one of only three sites t...ptimization Study for Multiple Sclerosis (TOP MS)....xamine the benefits of a,specialty pharmacy therap...patient outcomes. Targeted patient outcomes will i...
(Date:10/10/2008)...swire/ -- TriReme Medical Inc. (TMI),announced tod...nformite,Europeenne) marking and commercialize in ...ique main vessel stent system specially designed f...nting the next generation in bifurcation stenting,...rter of the 2.2 million,angioplasty procedures per...
Breaking Medicine Technology:Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 2Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 3Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests 4Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Spectros Corporation Reports 2007 Year Over Year Sales Rise 36 25 4279 1Spectros Corporation Reports 2007 Year Over Year Sales Rise 36 25 4279 2China Kangtai Cactus Biotech Inc Obtains 24500 000 Equity Financing 4276 1China Kangtai Cactus Biotech Inc Obtains 24500 000 Equity Financing 4276 2Abbotts XIENCE 28TM 29 V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years 1639 1Abbotts XIENCE 28TM 29 V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years 1639 2Abbotts XIENCE 28TM 29 V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years 1639 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 1Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 2Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 3Spirit II Results Support Strength of Boston Scientifics Two Drug Eluting Stent Platforms 1636 4
... 7, 2007 - ApoCell, Inc. presented the,results of ... of,Chicago and ApoCell at the 2007 annual meeting...O) held in Chicago in early June.,The study showed...,assay technology provides reliable predictive dat...fit of treating aggressive head,and neck cancer pa...
...WIRE)--Jun 8, 2007 - NuPathe Inc., a,privately hel...d,positive results from an initial Phase I study o...igraine being developed,by NuPathe., NP101 combine...tic transdermal technology with sumatriptan, the m... in the United,States. Sumatriptan is also the act...
Other Medicine Technology:ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 2NuPathe Reports Positive Phase One Results for NP101 Transdermal,Therapy for Acute Migraine 3
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: